Cross-sectional investigations of homelessness have many potential biases. Data from 2,452 individuals enrolled in a longitudinal cohort study of Baltimore, Maryland, residents recruited in 1988-1989 with a history of injection drug use were analyzed to identify the extent and determinants of homelessness. Proportions having ever experienced homelessness were compared across subgroups of injection drug users (IDUs) who were human immunodeficiency virus (HIV) negative, HW positive, and HIV seroconverting. Logistic regression identified independent predictors of homelessness. In the cohort, 1,144 (46.7%) participants experienced homelessness during the course of the study. There were differences in prevalence of homelessness by serostatus: 42.4% (n = 621) of participants who remained HIV negative were ever homeless, while 50.6% (n = 346) of HIV-infected individuals and 58.9% (n = 178) of those who seroconverted during the study were ever homeless (P < .001). Participants who consistently denied active injection drug use during follow-up were unlikely to experience homelessness (19%). Independent predictors of homelessness were male sex, HIV seroprevalence, and HIV seroconversion. Following participants over time captures more experiences of homelessness than cross-sectional studies and more accurately identifies risk characteristics. Our data suggest that homelessness is a significant problem among IDUs, especially those with HIV/AIDS.
INTRODUCTION
The associations among homelessness, drug use, and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) have been well described. The prevalence of drug use disorders among homeless individuals is approximately 30-40%, 1 with many studies demonstrating even higher prevalence rates. 2-4 Conversely, drug users report a high prevalence of homelessness. [5] [6] [7] [8] [9] The prevalence of HIV infection among homeless populations has been estimated as 3% in a national survey 1~ to local samples that have reported proportions from 9% to 62~ ~- 13 The proportion of homelessness among people living with HIV/ AIDS ranges anywhere from 8% to 64%. 5' 8A4-16 There are significant methodological difficulties in examining the relationship between homelessness and injection drug use or HIV/AIDS given the general instability and inaccessibility of these populations. The most important methodological barrier is the cross-sectional nature of most studies and the point prevalence bias that arises from this methodology. These studies measure homelessness either at one point in time or over a relatively short period of time and may underestimate true prevalence given the dynamic and transient nature of homelessness and drug use.
Regardless of the population source (e.g., street, shelter, clinic, hospital), a cross-sectional examination misses many of the "hidden homeless'lY--those who live in areas that are inaccessible to researchers or those who simply did not access a social service or health care facility during that period. Homeless people who currently are living with friends or relatives may also be overlooked) s In addition, a person who may have been homeless recently, but is housed currently may not self-identify as being homeless.
Since homeless people may be mistrustful of institutions 19 and given the stigmatization of their status, homeless individuals may also deny their true housing status. Some cross-sectional studies have also attempted to characterize the proportion of time spent homeless through the use of interviews. 2'1 This method of ascertainment may underestimate true experience 2~ because of problems of recall or social desirability.
Another possible bias introduced by cross-sectional investigations that is relevant especially to homeless populations is the potential oversampling of certain characteristics associated with frequent or chronic homelessness. For example, if a study is shelter based and a survey is performed at one point in time, it is likely that frequently or chronically homeless people will be over-represented.
Characteristics associated with chronically homeless people may then be overreported and may not be representative of the general homeless population or those who experience infrequent or one-time homelessness. Phelan and Link 21 recently demonstrated the magnitude of this bias in an elegant study through a comparison of data sets.
Given that a current state of homelessness is inadequate to account for housing instability, an estimate of lifetime or long-term prevalence may delineate better the economic, sociologic, and personal factors that may be predisposing factors. To explore further the associations among homelessness, drug use, and HIV/AIDS, we examined the prevalence of homelessness over an extended period of time among a prospective study of injection drug users (IDUs); at the time of this analysis, the study had the benefit of 10 years of continuous follow-up. We hypothesized that a longitudinal study would reveal more opportunities to capture experiences of homelessness than a cross-sectional approach. In addition, we explored the relationship between homelessness and HIV infection over time in relation to HIV serostatus. We hypothesized that the proportion of homelessness would be highest among those who were either infected with HIV at study entry or those who had become infected with HIV (seroconverters) during the course of follow-up.
Ms

STUDY SUBJs
The ALIVE (AIDS Links to the Intravenous Experience) study and its methods have been described in detail elsewhere. = The ALIVE cohort was recruited to identify risk factors for HIV infection and for progression to AIDS among those who used injection drugs. It was established in Baltimore, Maryland, in 1988 Maryland, in -1989 and is ongoing. Individual participants were recruited through a variety of means, including word of mouth, drug treatment programs, street outreach efforts, sexually transmitted disease and HIV clinics, the Maryland Division of Parole and Probation, and emergency rooms. These analyses were performed using information from the 2,452 individuals still enrolled in the study as of 1998. Of this cohort, 59.7% (n = 1,465) were HIV negative at baseline and remained so throughout the follow-up period (denoted as HIV negative), while 27.9% (n = 684) were HIV positive at baseline (denoted as HIV prevalent); 12.3% (n = 302)
were HIV negative at baseline, but were confirmed as having seroconverted during the course of follow-up (denoted as HIV seroconverters). Participants had follow-up visits every 6 months, during which interviewer-administered questionnaires and clinical data were collected.
STATISTICAL ANALYSIS
Homelessness was determined by a question that required self-definition of the condition: Have you been homeless at any time in the last 6 months? This question was asked at each visit and recorded as "yes," "no," or "don't know." For the purposes of analysis, "don't know" was recorded as "no." Duration or frequency of homelessness during each 6-month follow-up period was not assessed. Period prevalence of homelessness was calculated for the duration of the 6-month followup period. Drug use was calculated as the number of semesters that a participant claimed current drug use divided by the total number of follow-up visits for each individual.
Predictors of homelessness were assessed in univariate logistic regression models, for which the outcome variable was any homelessness reported during the follow-up period. All analyses were stratified by HIV status. Stepwise logistic regression analysis was utilized to assess the independent effect of variables that were significant in the univariate analyses at the 5% level on the outcome of homelessness.
RESULTS
STUDY SAMPLE
Of 2,452 participants enrolled in the ALIVE study in the current analysis, 2,281 (93.1%) were African-American; 1,201 participants (49.1%) of the sample had at least a high school degree; and 1,856 enrollees (75.7%) were male. The median age of the sample was 34 years at the time of enrollment. Of the sample, 12% (n = 294) reported no active drug use ever during the course of the study (Table I) .
PREVALENCE OF HOMELESSNESS
A total of 1,144 participants (46.7%) of the overall cohort experienced homelessness at least once during the follow-up period ("ever homeless"). There were marked and significant differences in the period prevalence of homelessness between groups when stratified by serostatus. Of HIV-negative subjects, 621 (42.4%) were ever homeless, while 346 (50.6%) of HIV-prevalent subjects were ever homeless. Relative to these groups, a higher proportion of HIV seroconverters, 58.9% (n = 178), were ever homeless (P < .001; see Table I ).
PREDICTORS AND CHARACTERISTICS OF HOMELESSNESS
Univariate analysis demonstrated that current drug use predicted homelessness, with the strength of the association increasing with frequency of active drug use (Table II) . Participants who denied injection drug use consistently during the course of the follow-up were least likely to experience homelessness (19%) regardless of HIV serostatus. Gender and serostatus were predictive of ever reporting homeless in univariate analyses (Table II) , while age, race, and education were (Table III) .
DISCUSSION
We observed a high prevalence of homelessness over a 10-year study period in this longitudinal cohort of former and current IDUs. Nearly half of our sample (46.7%) claimed to have been homeless at least once during follow-up. Our prevalence estimate of homelessness is higher than reported in other studies and is consistent with our hypothesis that a prolonged period of observation reveals more frequent reports of hornelessness.
Link et al. 17 examined the lifetime prevalence of homelessness using a telephone sample of currently housed people in New York City and estimated that Interestingly, the baseline data in the ALIVE study reported a prevalence of homelessness of 11%, 7 clearly demonstrating that a longer period of observation will yield a higher prevalence.
Examination of current drug use in our study supports several reports of a positive association between drug use and homelessness. ~-5'u'~4 In addition, our data demonstrate that more frequent drug use is a stronger predictor for homelessness than less-frequent use. These data--made possible by the study's longitudinal design--suggest a more intimate relationship between drug use and homelessness than previously observed in cross-sectional investigations and are less likely to reflect point prevalence bias.
We also observed significant differences in homelessness by HIV status that were not explained by sociodemographic factors. Our findings support others that demonstrate a strong link between HIV/AIDS and homelessness, n-13 In our study, 46% of IDUs who experienced homelessness were HIV positive at the time of analysis, compared to 35% prevalence of HIV infection among those who never experienced homelessness. Moreover, our study uncovered an important relationship between homelessness and HIV seroconversion. In multivariate logistic regression models, HIV seroconverters were twice as likely to be homeless.
A previous case-control study of IDUs found unstable housing to be predictive of HIV seroconversion. 27 One explanation for these findings is that the instability As in other longitudinal studies, this study is limited by volunteer bias, reporting bias, and incomplete data for some individuals. In other studies, homeless individuals may have been less likely to enroll because of their isolation and less-frequent contact with health care and social service institutions. However, this bias may not have operated as strongly in the ALIVE cohort since participants were provided with a monetary reimbursement at each visit and referrals to services. Indeed, the trend in our study was for homeless people to attend study visits more frequently and to be followed for longer than those who never experienced homelessness.
Another potential source of bias is our study definition of homelessness; as we could not validate their self-reports, it is possible that participants could have misrepresented their experience. However, homeless individuals usually underreport their homelessness (e.g., by not understanding that living transiently with friends may be considered as homelessness). We tried to compensate for this in our analysis by including "don't know" responses with "no" responses, thereby potentially underestimating the true frequency. Finally, another limitation to our findings is the lack of generalizability.
The strength of this study is its longitudinal design with excellent retention of participants; individuals were followed for 10 years, providing up to 20 evaluations. Thus, prevalence measurements of homelessness are less likely to suffer from biases borne of cross-sectional studies, and associations are less likely to reflect bias borne of oversampling frequently or chronically homeless individuals.
Several important conclusions can be drawn from our observations. First, longitudinal studies capture more instances of homelessness and may portray better the extent of the homeless problem in many urban centers. Next, using longitudinal data describes a much more intimate relationship between homelessness and drug use and HIV/AIDS than previously described. As homeless people face barriers accessing health care and appear to be at higher risk of HIV infection, these findings have important implications for primary care and public health.
